Literature DB >> 28641539

Role of Host Factors on the Regulation of Tat-Mediated HIV-1 Transcription.

Guillaume Mousseau1, Susana T Valente1.   

Abstract

BACKGROUND: The viral transactivator Tat protein is a key modulator of HIV-1 replication, as it regulates transcriptional elongation from the integrated proviral genome. Tat recruits the human transcription elongation factor b, and other host proteins, such as the super elongation complex, to activate the cellular RNA polymerase II, normally stalled shortly after transcription initiation at the HIV promoter. By means of a complex set of interactions with host cellular factors, Tat determines the fate of viral activity within the infected cell. The virus will either actively replicate to promote dissemination in blood and tissues, or become dormant mostly in memory CD4+ T cells, as part of a small but long-living latent reservoir, the main obstacle for HIV eradication.
OBJECTIVE: In this review, we summarize recent advances in the understanding of the multi-step mechanism that regulates Tat-mediated HIV-1 transcription and RNA polymerase II release, to promote viral transcription elongation. Early events of the human transcription elongation factor b release from the inhibitory 7SK small nuclear ribonucleoprotein complex and its recruitment to the HIV promoter will be discussed. Specific roles of the super elongation complex subunits during transcription elongation, and insight on recently identified cellular factors and mechanisms regulating HIV latency will be detailed.
CONCLUSION: Understanding the complexity of HIV transcriptional regulation by host factors may open the door for development of novel strategies to eradicate the resilient latent reservoir. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  7SK snRNP; HIV latency; P-TEFb; SEC; Tat; Tat-dependent HIV transcription; host factors

Mesh:

Substances:

Year:  2017        PMID: 28641539      PMCID: PMC5731639          DOI: 10.2174/1381612823666170622104355

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  143 in total

Review 1.  The super elongation complex (SEC) family in transcriptional control.

Authors:  Zhuojuan Luo; Chengqi Lin; Ali Shilatifard
Journal:  Nat Rev Mol Cell Biol       Date:  2012-08-16       Impact factor: 94.444

2.  Synthesis of functional human immunodeficiency virus tat protein in baculovirus as determined by a cell-cell fusion assay.

Authors:  K T Jeang; P R Shank; A B Rabson; A Kumar
Journal:  J Virol       Date:  1988-10       Impact factor: 5.103

3.  BET bromodomain inhibition as a novel strategy for reactivation of HIV-1.

Authors:  Camellia Banerjee; Nancie Archin; Daniel Michaels; Anna C Belkina; Gerald V Denis; James Bradner; Paola Sebastiani; David M Margolis; Monty Montano
Journal:  J Leukoc Biol       Date:  2012-07-16       Impact factor: 4.962

4.  The SWI/SNF chromatin-remodeling complex is a cofactor for Tat transactivation of the HIV promoter.

Authors:  Tokameh Mahmoudi; Maribel Parra; Robert G J Vries; Steven E Kauder; C Peter Verrijzer; Melanie Ott; Eric Verdin
Journal:  J Biol Chem       Date:  2006-05-10       Impact factor: 5.157

5.  An analog of the natural steroidal alkaloid cortistatin A potently suppresses Tat-dependent HIV transcription.

Authors:  Guillaume Mousseau; Mark A Clementz; Wendy N Bakeman; Nisha Nagarsheth; Michael Cameron; Jun Shi; Phil Baran; Rémi Fromentin; Nicolas Chomont; Susana T Valente
Journal:  Cell Host Microbe       Date:  2012-07-19       Impact factor: 21.023

6.  FACT Proteins, SUPT16H and SSRP1, Are Transcriptional Suppressors of HIV-1 and HTLV-1 That Facilitate Viral Latency.

Authors:  Huachao Huang; Netty Santoso; Derek Power; Sydney Simpson; Michael Dieringer; Hongyu Miao; Katerina Gurova; Chou-Zen Giam; Stephen J Elledge; Jian Zhu
Journal:  J Biol Chem       Date:  2015-09-16       Impact factor: 5.157

7.  Crystal structure of HIV-1 Tat complexed with human P-TEFb.

Authors:  Tahir H Tahirov; Nigar D Babayeva; Katayoun Varzavand; Jeffrey J Cooper; Stanley C Sedore; David H Price
Journal:  Nature       Date:  2010-06-10       Impact factor: 49.962

8.  Bromodomain and extra-terminal (BET) bromodomain inhibition activate transcription via transient release of positive transcription elongation factor b (P-TEFb) from 7SK small nuclear ribonucleoprotein.

Authors:  Koen Bartholomeeusen; Yanhui Xiang; Koh Fujinaga; B Matija Peterlin
Journal:  J Biol Chem       Date:  2012-09-05       Impact factor: 5.157

9.  Structural insight into the mechanism of stabilization of the 7SK small nuclear RNA by LARP7.

Authors:  Emiko Uchikawa; Kundhavai S Natchiar; Xiao Han; Florence Proux; Pierre Roblin; Elodie Zhang; Alexandre Durand; Bruno P Klaholz; Anne-Catherine Dock-Bregeon
Journal:  Nucleic Acids Res       Date:  2015-03-09       Impact factor: 16.971

10.  HMGA1 recruits CTIP2-repressed P-TEFb to the HIV-1 and cellular target promoters.

Authors:  Sebastian Eilebrecht; Valentin Le Douce; Raphael Riclet; Brice Targat; Houda Hallay; Benot Van Driessche; Christian Schwartz; Gwenaëlle Robette; Carine Van Lint; Olivier Rohr; Arndt G Benecke
Journal:  Nucleic Acids Res       Date:  2014-03-11       Impact factor: 16.971

View more
  19 in total

1.  Structural mechanism for HIV-1 TAR loop recognition by Tat and the super elongation complex.

Authors:  Ursula Schulze-Gahmen; James H Hurley
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-04       Impact factor: 11.205

Review 2.  Face-time with TAR: Portraits of an HIV-1 RNA with diverse modes of effector recognition relevant for drug discovery.

Authors:  Sai Shashank Chavali; Rachel Bonn-Breach; Joseph E Wedekind
Journal:  J Biol Chem       Date:  2019-05-12       Impact factor: 5.157

3.  The TAR binding dynamics and its implication in Tat degradation mechanism.

Authors:  Shangbo Ning; Chengwei Zeng; Chen Zeng; Yunjie Zhao
Journal:  Biophys J       Date:  2021-11-09       Impact factor: 4.033

4.  Gliotoxin, identified from a screen of fungal metabolites, disrupts 7SK snRNP, releases P-TEFb, and reverses HIV-1 latency.

Authors:  Mateusz Stoszko; Abdullah M S Al-Hatmi; Anton Skriba; Michael Roling; Enrico Ne; Raquel Crespo; Yvonne M Mueller; Mohammad Javad Najafzadeh; Joyce Kang; Renata Ptackova; Elizabeth LeMasters; Pritha Biswas; Alessia Bertoldi; Tsung Wai Kan; Elisa de Crignis; Miroslav Sulc; Joyce H G Lebbink; Casper Rokx; Annelies Verbon; Wilfred van Ijcken; Peter D Katsikis; Robert-Jan Palstra; Vladimir Havlicek; Sybren de Hoog; Tokameh Mahmoudi
Journal:  Sci Adv       Date:  2020-08-12       Impact factor: 14.136

5.  Combined HIV-1 Tat and oxycodone activate the hypothalamic-pituitary-adrenal and -gonadal axes and promote psychomotor, affective, and cognitive dysfunction in female mice.

Authors:  Mohammed F Salahuddin; Alaa N Qrareya; Fakhri Mahdi; Dejun Jackson; Matthew Foster; Tamara Vujanovic; J Gaston Box; Jason J Paris
Journal:  Horm Behav       Date:  2019-12-13       Impact factor: 3.587

Review 6.  Targeting HIV-1 proviral transcription.

Authors:  Alex Olson; Binita Basukala; Wilson W Wong; Andrew J Henderson
Journal:  Curr Opin Virol       Date:  2019-08-29       Impact factor: 7.121

7.  The Tat inhibitor didehydro-cortistatin A suppresses SIV replication and reactivation.

Authors:  Sonia Mediouni; Cari F Kessing; Joseph A Jablonski; Suzie Thenin-Houssier; Mark Clementz; Melia D Kovach; Guillaume Mousseau; Ian Mitchelle S de Vera; Chuan Li; Douglas J Kojetin; David T Evans; Susana T Valente
Journal:  FASEB J       Date:  2019-04-25       Impact factor: 5.834

8.  Didehydro-Cortistatin A Inhibits HIV-1 by Specifically Binding to the Unstructured Basic Region of Tat.

Authors:  Sonia Mediouni; Krishna Chinthalapudi; Mary K Ekka; Ippei Usui; Joseph A Jablonski; Mark A Clementz; Guillaume Mousseau; Jason Nowak; Venkat R Macherla; Jacob N Beverage; Eduardo Esquenazi; Phil Baran; Ian Mitchelle S de Vera; Douglas Kojetin; Erwann P Loret; Kendall Nettles; Souvik Maiti; Tina Izard; Susana T Valente
Journal:  mBio       Date:  2019-02-05       Impact factor: 7.867

Review 9.  Cat and Mouse: HIV Transcription in Latency, Immune Evasion and Cure/Remission Strategies.

Authors:  Aurélie Delannoy; Mikaël Poirier; Brendan Bell
Journal:  Viruses       Date:  2019-03-18       Impact factor: 5.048

Review 10.  Long Non-coding RNAs: Regulators of Viral Infection and the Interferon Antiviral Response.

Authors:  Lipeng Qiu; Tao Wang; Qi Tang; Guohui Li; Peng Wu; Keping Chen
Journal:  Front Microbiol       Date:  2018-07-19       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.